{"name":"Li-jun Ding","slug":"li-jun-ding","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE93a2NxSVJVR0ZMUTc1OWp2aFRRREV2aVI1THFBdy1sU2NaUUxiYXZwcVFSMjV5Mnk2eVZJWjI1Zy1ZamQ2OUllTFZ3SjB1cFJpcU9yRy1fc1ZGRGN5dFQ4?oc=5","date":"2025-08-26","type":"pipeline","source":"Nature","summary":"Mevalonate metabolites boost aged oocyte quality through prenylation of small GTPases - Nature","headline":"Mevalonate metabolites boost aged oocyte quality through prenylation of small GTPases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9vNGFzOURBWjNQaTlBbTAxNHNENVp1eHVfWk9RMnk4Y0UzeDhQTGlUYVFobUtnSjhrNVFWRTJMZEpsbFFsRkhGTVY5Y0p5SU5YSHF2Sy1rUG5YdzNMQjlv?oc=5","date":"2022-07-13","type":"pipeline","source":"Nature","summary":"Umbilical cord artery-derived perivascular stem cells for treatment of ovarian failure through CD146 signaling - Nature","headline":"Umbilical cord artery-derived perivascular stem cells for treatment of ovarian failure through CD146 signaling","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE1RTmYtNzQ3dVo1UUsyWG9NSXQtTklHQW5qcl9fdjRSY3BnQm9qc2E2enEwVTc4VDNoM0Z5Vm91aE81UVh6cW9pN1RPLXhiYWVoaWh3?oc=5","date":"2015-10-08","type":"pipeline","source":"Nature","summary":"Hetero-modification of TRAIL trimer for improved drug delivery and in vivo antitumor activities - Nature","headline":"Hetero-modification of TRAIL trimer for improved drug delivery and in vivo antitumor activities","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}